“Influences of SGLT2 inhibitors on the cardiovascular system of patients with type 2 Diabetes mellitus: an integrative review”, RSD, vol. 11, no. 16, p. e172111638091, Dec. 2022, doi: 10.33448/rsd-v11i16.38091.